Mark N. Ho

1.0k total citations · 1 hit paper
5 papers, 608 citations indexed

About

Mark N. Ho is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Mark N. Ho has authored 5 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 1 paper in Pharmacology. Recurrent topics in Mark N. Ho's work include Ubiquitin and proteasome pathways (3 papers), Peptidase Inhibition and Analysis (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Mark N. Ho is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Peptidase Inhibition and Analysis (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Mark N. Ho collaborates with scholars based in United States. Mark N. Ho's co-authors include Maya Dajee, Francesco Parlati, Kevin D. Shenk, Guy J. Laidig, Susan D. Demo, Mark K. Bennett, Mark S. Smyth, Congcong Sun, Christopher J. Kirk and Monette Aujay and has published in prestigious journals such as Blood, Cancer Research and Journal of Pharmacy and Pharmacology.

In The Last Decade

Mark N. Ho

5 papers receiving 593 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome

2007 542 citations Susan D. Demo, Christopher J. Kirk et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark N. Ho United States	3	494	254	220	48	45	5	608
Shohei Mizuno Japan	13	301 0.6×	286 1.1×	102 0.5×	37 0.8×	39 0.9×	56	635
Stefan J. Müller Germany	7	205 0.4×	226 0.9×	173 0.8×	32 0.7×	17 0.4×	11	460
Wanmao Ni China	11	292 0.6×	215 0.8×	73 0.3×	50 1.0×	104 2.3×	20	507
Shishinn Sun United States	11	245 0.5×	117 0.5×	107 0.5×	47 1.0×	59 1.3×	15	474
Hsiao-Ling Hung United States	7	424 0.9×	171 0.7×	48 0.2×	59 1.2×	21 0.5×	8	640
Leeona Galligan United Kingdom	8	384 0.8×	78 0.3×	264 1.2×	27 0.6×	42 0.9×	9	591
Mandy Mayo Aust United States	5	289 0.6×	95 0.4×	79 0.4×	49 1.0×	39 0.9×	7	370
Debora Valli Italy	12	263 0.5×	109 0.4×	92 0.4×	35 0.7×	15 0.3×	14	417
Mushtaq Ashraf Pakistan	7	287 0.6×	163 0.6×	72 0.3×	131 2.7×	54 1.2×	10	534
Savita Bhalla United States	9	211 0.4×	30 0.1×	109 0.5×	27 0.6×	38 0.8×	19	355

Countries citing papers authored by Mark N. Ho

Since Specialization

Citations

This map shows the geographic impact of Mark N. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Ho more than expected).

Fields of papers citing papers by Mark N. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark N. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Ho. The network helps show where Mark N. Ho may publish in the future.

Co-authorship network of co-authors of Mark N. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Mark N. Ho. A scholar is included among the top collaborators of Mark N. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark N. Ho. Mark N. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Demo, Susan D., Christopher J. Kirk, Monette Aujay, et al.. (2007). Antitumor Activity of PR-171, a Novel Irreversible Inhibitor of the Proteasome. Cancer Research. 67(13). 6383–6391. 542 indexed citations breakdown →

2.

Furimsky, Anna, Mark N. Ho, Yi Li, et al.. (2006). Glucuronidation oftrans-resveratrol by human liver and intestinal microsomes and UGT isoforms. Journal of Pharmacy and Pharmacology. 58(4). 469–479. 61 indexed citations

3.

Yang, Jinfu, et al.. (2006). Metabolism, Disposition and Pharmacokinetics of PR-171, a Novel Inhibitor of the 20S Proteasome.. Blood. 108(11). 5067–5067. 1 indexed citations

4.

Kirk, Christopher J., Mark K. Bennett, Tonia J. Buchholz, et al.. (2005). Pharmacokinetics, Pharmacodynamics and Anti-Tumor Efficacy of PR-171, a Novel Inhibitor of the 20S Proteasome.. Blood. 106(11). 609–609. 2 indexed citations

5.

Iyer, Lalitha, Mark N. Ho, Anna Furimsky, et al.. (2004). In vitro metabolism and interaction studies with celecoxib and lovastatin.. 64. 488–488. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact